vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PJT Partners Inc. (PJT). Click either name above to swap in a different company.

PJT Partners Inc. is the larger business by last-quarter revenue ($531.4M vs $270.8M, roughly 2.0× HUTCHMED (China) Ltd). PJT Partners Inc. runs the higher net margin — 10.0% vs 0.7%, a 9.3% gap on every dollar of revenue. On growth, PJT Partners Inc. posted the faster year-over-year revenue change (12.9% vs -16.5%). PJT Partners Inc. produced more free cash flow last quarter ($138.6M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.

HCM vs PJT — Head-to-Head

Bigger by revenue
PJT
PJT
2.0× larger
PJT
$531.4M
$270.8M
HCM
Growing faster (revenue YoY)
PJT
PJT
+29.5% gap
PJT
12.9%
-16.5%
HCM
Higher net margin
PJT
PJT
9.3% more per $
PJT
10.0%
0.7%
HCM
More free cash flow
PJT
PJT
$135.2M more FCF
PJT
$138.6M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
PJT
PJT
Revenue
$270.8M
$531.4M
Net Profit
$2.0M
$53.4M
Gross Margin
37.7%
Operating Margin
-13.2%
23.1%
Net Margin
0.7%
10.0%
Revenue YoY
-16.5%
12.9%
Net Profit YoY
-83.6%
4.0%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PJT
PJT
Q4 25
$270.8M
$531.4M
Q3 25
$442.3M
Q2 25
$277.7M
$401.1M
Q1 25
$324.5M
$321.9M
Q4 24
$470.5M
Q3 24
$320.3M
Q2 24
$305.7M
$358.1M
Q1 24
$327.1M
Net Profit
HCM
HCM
PJT
PJT
Q4 25
$2.0M
$53.4M
Q3 25
$39.8M
Q2 25
$455.0M
$32.9M
Q1 25
$11.9M
$54.0M
Q4 24
$51.3M
Q3 24
$22.1M
Q2 24
$25.8M
$28.3M
Q1 24
$32.6M
Gross Margin
HCM
HCM
PJT
PJT
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
PJT
PJT
Q4 25
-13.2%
23.1%
Q3 25
20.6%
Q2 25
-1.3%
19.1%
Q1 25
-5.0%
16.3%
Q4 24
21.9%
Q3 24
15.4%
Q2 24
-9.0%
18.0%
Q1 24
16.5%
Net Margin
HCM
HCM
PJT
PJT
Q4 25
0.7%
10.0%
Q3 25
9.0%
Q2 25
163.8%
8.2%
Q1 25
3.7%
16.8%
Q4 24
10.9%
Q3 24
6.9%
Q2 24
8.4%
7.9%
Q1 24
10.0%
EPS (diluted)
HCM
HCM
PJT
PJT
Q4 25
$0.00
Q3 25
Q2 25
$0.52
Q1 25
$0.01
Q4 24
Q3 24
Q2 24
$0.03
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PJT
PJT
Cash + ST InvestmentsLiquidity on hand
$1.4B
$538.9M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$308.2M
Total Assets
$1.8B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PJT
PJT
Q4 25
$1.4B
$538.9M
Q3 25
$400.5M
Q2 25
$1.4B
$214.6M
Q1 25
$836.1M
$194.3M
Q4 24
$483.9M
Q3 24
$148.8M
Q2 24
$802.5M
$164.2M
Q1 24
$215.5M
Total Debt
HCM
HCM
PJT
PJT
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PJT
PJT
Q4 25
$1.2B
$308.2M
Q3 25
$228.6M
Q2 25
$1.2B
$167.4M
Q1 25
$759.9M
$148.8M
Q4 24
$187.0M
Q3 24
$159.1M
Q2 24
$740.1M
$133.8M
Q1 24
$174.6M
Total Assets
HCM
HCM
PJT
PJT
Q4 25
$1.8B
$1.8B
Q3 25
$1.7B
Q2 25
$1.8B
$1.5B
Q1 25
$1.3B
$1.4B
Q4 24
$1.6B
Q3 24
$1.6B
Q2 24
$1.3B
$1.4B
Q1 24
$1.3B
Debt / Equity
HCM
HCM
PJT
PJT
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PJT
PJT
Operating Cash FlowLast quarter
$8.2M
$155.7M
Free Cash FlowOCF − Capex
$3.4M
$138.6M
FCF MarginFCF / Revenue
1.2%
26.1%
Capex IntensityCapex / Revenue
1.8%
3.2%
Cash ConversionOCF / Net Profit
4.21×
2.92×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$480.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PJT
PJT
Q4 25
$8.2M
$155.7M
Q3 25
$256.1M
Q2 25
$-72.9M
$190.4M
Q1 25
$40.3M
$-75.9M
Q4 24
$195.7M
Q3 24
$180.5M
Q2 24
$-39.8M
$193.6M
Q1 24
$-38.8M
Free Cash Flow
HCM
HCM
PJT
PJT
Q4 25
$3.4M
$138.6M
Q3 25
$240.9M
Q2 25
$-82.2M
$178.9M
Q1 25
$32.5M
$-77.9M
Q4 24
$195.3M
Q3 24
$178.5M
Q2 24
$-49.9M
$193.0M
Q1 24
$-39.2M
FCF Margin
HCM
HCM
PJT
PJT
Q4 25
1.2%
26.1%
Q3 25
54.5%
Q2 25
-29.6%
44.6%
Q1 25
10.0%
-24.2%
Q4 24
41.5%
Q3 24
55.7%
Q2 24
-16.3%
53.9%
Q1 24
-12.0%
Capex Intensity
HCM
HCM
PJT
PJT
Q4 25
1.8%
3.2%
Q3 25
3.4%
Q2 25
3.3%
2.9%
Q1 25
2.4%
0.6%
Q4 24
0.1%
Q3 24
0.6%
Q2 24
3.3%
0.1%
Q1 24
0.1%
Cash Conversion
HCM
HCM
PJT
PJT
Q4 25
4.21×
2.92×
Q3 25
6.43×
Q2 25
-0.16×
5.79×
Q1 25
3.38×
-1.41×
Q4 24
3.81×
Q3 24
8.15×
Q2 24
-1.54×
6.84×
Q1 24
-1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons